About Dren Bio
Dren Bio is a privately held, biopharmaceutical company focused on developing therapeutic antibodies for the treatment of cancer, autoimmune and other serious diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Round
Global Headquarters
Undisclosed
Tracked Since
Oct 29, 2026
Web & Domain Identity
Official Website
drenbio.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@companies
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $350,000,000 · Round
Backed by Juvia Group
- Capital Raise
Raised $65,000,000 · Series-B
Backed by HBM Healthcare Investments
- Capital Raise
Series-A announced
Backed by SR One
Investors & Backers
HBM Healthcare Investments
Lead
Juvia Group
Lead
SR One
Lead
8VC
Alexandria Venture Investments
ArrowMark Partners
Biotechnology Value Fund
Cormorant Asset Management
General Catalyst
HBM Partners
Jacket River
Lightspeed
Mirae Asset Capital Life Science
Mission BioCapital
OrbiMed
Pfizer Venture Investments
Revelation Partners
Taiho Ventures
Funding History
Round equity
· Oct 29, 2026
Round backers: Juvia Group
$350,000,000 finance.yahoo.com
Series-B equity
· Jun 14, 2022
Round backers: HBM Healthcare Investments
$65,000,000 zpr.io
Series-A equity
· Oct 16, 2020
Round backers: SR One
Undisclosed zpr.io
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
INFevo
infevo.ai
Seed Beijing · Nov 2026
Seawolf Therapeutics
seawolftx.com
Seed San Diego · Nov 2026